PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-Dec-2020 AlzeCure receives approval to start clinical Phase Ib trial with ACD440 in neuropathic pain AlzeCure Pharma AB
09-Dec-2020 YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY Kite, a Gilead Company
09-Dec-2020 I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China I-Mab
09-Dec-2020 Creating a win:win dialogue between NHS and pharma industry to support the spread and scale of innovation BOB.health
09-Dec-2020 Thermo Fisher Scientific Releases New CE-Marked COVID-19, Flu A/B, RSV Combo Kit Thermo Fisher Scientific
09-Dec-2020 New Research Roadmap sets a course towards a cure for osteoporosis Royal Osteoporosis Society
09-Dec-2020 Sanofi pioneers sustainable finance in the pharmaceutical industry with the signing of its two first sustainability-linked revolving credit facilities Sanofi
09-Dec-2020 Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil Amryt
09-Dec-2020 Enara Bio relocates to The Oxford Science Park’s newest facility to expand R&D capabilities in the search for novel cancer immunotherapies Enara Bio
09-Dec-2020 New Clinical Trial Data Demonstrates BD Libertas™ Wearable Injector as a Drug Delivery System Becton, Dickinson and Company
09-Dec-2020 MEDICAL VIDEO LIBRARY ADDED TO ENHANCE DIGITAL TRIAGE AND GP CONSULTATIONS eConsult Health, HCI and Cognitant Group
09-Dec-2020 Creative Diagnostics Further Launches SARS-CoV-2 Magnetic Particles in Response to COVID-19 Creative Diagnostics
09-Dec-2020 CD Bioparticles Introduces Innovative Fluorescent Polymers to Support Research CD Bioparticles
09-Dec-2020 Elasmogen Announces Grants Of 2 New VNAR and soloMER Patent Families Elasmogen
09-Dec-2020 Elasmogen Announces Grants Of 2 New VNAR and soloMER Patent Families Elasmogen
08-Dec-2020 Top-line Final Data from Cantrixil Phase I Study Confirms Prior Positive Efficacy and Safety Signals Kazia Therapeutics Ltd
08-Dec-2020 Rational Vaccines believes live-attenuated virus vaccine development is the right approach Rational Vaccines
08-Dec-2020 Entrada Therapeutics Strengthens Leadership Team with Key Appointments Entrada Therapeutics
08-Dec-2020 PFIZER REPORTS POSITIVE CLINICAL DATA FOR BCMA-CD3 BISPECIFIC ANTIBODY (PF-06863135) IN MULTIPLE MYELOMA Pfizer
08-Dec-2020 Roche presents new data from its bispecific antibody portfolio across a range of blood cancers Roche